Home > Insider Trading > Filing (0001209191-20-042500)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661460	Poseida Therapeutics Inc.	PSTX	Biological Products, (No Disgnostic Substances) (2836)	472846548

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1685042	Sean Murphy	C/O Poseida Therapeutics, Inc. 9390 Towne Centre Drive, Suite 200 San Diego CA 92121		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-07-14	7,013,918	$0.00	7,013,918	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-07-14	1,168,985	$0.00	8,182,903	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-07-14	690,124	$0.00	8,873,027	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-07-14	315,098	$0.00	9,188,125	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-07-14	10,000	$16.00	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2020-07-14	8,746,356	$0.00	7,013,918	$0.00
Common Stock	Series A-1 Preferred Stock	Disposition	2020-07-14	1,457,725	$0.00	1,168,985	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-07-14	860,585	$0.00	690,124	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-07-14	392,927	$0.00	315,098	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of the Issuer's Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
Represents shares of common stock issuable upon conversion of preferred stock held by Malin Holdings, a wholly owned subsidiary of Malin Corporation plc ("Malin"), and may be deemed to be beneficially owned by Malin. Malin may be deemed to share voting and investment power over securities held by Malin Holdings. Mr. Murphy currently serves as a member of the leadership team at Malin. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.